Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

  • ID: 4090196
  • Report
  • Region: Global
  • 150 Pages
  • BCC Research
1 of 6
The Global Market for Over the Counter (OTC) Drugs and Dietary Supplements Reached $164.7 Billion in 2016 and Should Reach $220.8 Billion in 2021

FEATURED COMPANIES

  • Alacer Corp.
  • Bausch & Lomb
  • Daiichi Sankyo Co., Ltd.
  • Glaxosmithkline Plc
  • Neutrogena Corp.
  • Reckitt Benckiser Plc.
  • MORE

The Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets Report Includes:

  • An overview of the global markets for OTC drugs and dietary supplements
  • Analyses of global market trends, with data from 2015, 2016, and projections of CAGRs through 2021
  • Information about how pharmacies affect the OTC drug market
  • Analysis of new developments that will provide an opportunity to manufacturers and marketers of OTC medicines and dietary supplements to expand organically
  • Updates on the latest merger and acquistion activity
  • Coverage of how point of sales and channels of distribution drive sales of OTC drugs and dietary supplements
  • A look at key strategic initiatives for market penetration and expansion
  • Company profiles of major players in the field

Report Scope

The report considers only western or modern drugs for this report and excludes any other type of drugs such as alternative therapies.

This study aims at understanding the dynamics and forecasts for OTC drugs and dietary supplements markets worldwide and provides key market propositions within the next five-year period.

The report covers developed and emerging markets in order to help readers understand:

  • The current state of the OTC drugs and dietary supplements market and the key markets for its future development.
  • New regulations that will influence the development of the OTC drugs and dietary supplements market.
  • Market drivers of and threats to the OTC drugs and dietary supplements industry.
  • Major regional trends in the global OTC drugs and dietary supplements market.

Highlights:

  • The global market for over the counter (OTC) drugs and dietary supplements reached $164.7 billion in 2016 and should reach $220.8 billion in 2021, with a compound annual growth rate (CAGR) of 6.0%.
  • Dietary supplements as a segment reached $55.8 billion in 2016 and should reach $74.8 billion in 2021, with a CAGR of 6.1%.
  • Oral medical care as a segment reached nearly $22.9 billion in 2016 and should reach $32.1 billion 2021, with a CAGR of 7.0%.

Intended Audience

  • Executives of pharmaceutical companies that are currently marketing OTC drugs and dietary supplements.
  • Executives of companies that provide third-party manufacturing and development facilities for OTC drugs and dietary supplements.
  • Manufacturers of bulk active ingredients and inactive ingredients such as base, resins, pigments and other raw materials for the manufacturing of OTC drugs and dietary supplements.
  • FMCG companies that intend to enter the OTC drugs and dietary supplements market.
  • Entrepreneurs, management consultants, and merger and acquisition (M&A) consultants.
  • Financial institutions, venture capitalists and angel investors.
  • Manufacturers and exporters of alternate OTC drugs and food supplements.
  • Government agencies, public health departments and organizations working in regulations and process development of OTC drugs and dietary supplements.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Alacer Corp.
  • Bausch & Lomb
  • Daiichi Sankyo Co., Ltd.
  • Glaxosmithkline Plc
  • Neutrogena Corp.
  • Reckitt Benckiser Plc.
  • MORE

1: Introduction

  • Study Goals And Objectives
  • Reasons For Doing The Study
  • Scope Of Report
  • Intended Audience
  • Information Sources

2: Summary

  • Global OTC Drug Markets By Leading Therapeutic Segments, 2016 Through 2021
  • Global Dietary Supplement Markets, 2016 Through 2021

3: Overview

  • Evolution Of OTC Drugs
  • Key Growth Factors For OTC Drugs And Dietary Supplement Markets
  • Industry Drivers For OTC Drugs
  • Rules And Regulations For OTC Drugs And Dietary Supplements
  • Markets For OTC Drugs And Dietary Supplements

4: Global OTC Drugs And Dietary Supplement Markets

  • Global Markets For OTC Drugs And Dietary Supplements 2016 Through 2021
  • Regional Markets For OTC Drugs And Dietary Supplement Markets 2016 Through 2021
  • Global Sales Forecast For OTC Drugs By Therupeutic Classification
  • Global OTC Drugs And Dietary Supplement Markets By Location Of Sales 2016 Through 2021

5: OTC Drugs And Dietary Supplement Markets In The Americas

  • OTC Drugs And Dietary Supplement Markets In North America 2016 Through 2021
  • OTC Drugs And Dietary Supplements In The U.S.
  • Vendor Ecosystem For OTC Drugs In The U.S.

6: The OTC Drug And Dietary Supplement Markets In Europe

  • Brexit Effect On The OTC Drug Market In Europe
  • OTC Drugs And Dietary Supplement Markets In Europe 2016 - 2021
  • OTC Drugs And Dietary Supplement Markets: Western Europe Through 2021
  • The U.K. OTC Drug Market
  • German OTC Drug And Dietary Supplements Market
  • France's OTC Drugs Market 2016 Through 2021
  • OTC Drugs And Dietary Supplement Markets In Central And Eastern Europe

7: OTC Drugs And Dietary Supplement Markets In Asia-Pacific

  • Apac OTC Drugs Markets 2016 Through 2021

8: Global Market Forecast For OTC Drugs By Therupeutic Classification

  • OTC Analgesics/Antipyretics Markets 2021
  • OTC Antihistamine And Cough And Cold Drugs Markets 2021
  • OTC Gastrointestinal Products Markets 2021
  • OTC Dermatological Drugs Markets 2021
  • OTC Oral Medical Care Products Markets 2021
  • Global Market Forecast For OTC Eye Care Products
  • OTC Smoking Cessation Products Markets 2021
  • OTC Dietary Supplements (Vms) Markets 2021
  • Global Market Forecast Through 2021

9: OTC Drug Industry Roadmap

  • The Practice Of Buying OTC Drugs
  • Role Of Pharmacy In OTC Drugs
  • Regulatory Influence On OTC Drug Market
  • Key Strategic Initiatives For Market Penetration And Expansion
  • Drivers Of And Barriers To The OTC Drug Industry
  • Strengths, Weaknesses, Opportunities And Threats (Swot) Analysis Of The OTC Drug And Dietary Supplement Industry

10: Company Profiles

  • Alacer Corp.
  • Alcon Inc.
  • Alfresa Pharma Corporation
  • Alkalon A/S
  • Alliance Healthcare
  • Allergan, Plc.
  • Alticor
  • Arkopharma Pharmaceutical Laboratories (Laboratoires Pharmaceutiques)
  • Aspen Holdings
  • Bausch & Lomb
  • Bayer Healthcare AG
  • Boehringer Ingelheim GMBH
  • Carma Laboratories, Inc.
  • Chattem Inc.
  • Cilag AG
  • Colgate-Palmolive Company
  • Daiichi Sankyo Co., Ltd.
  • Derma Sciences
  • Eyescience Labs
  • Fertin Pharma A/S
  • Gaba Gmbh, PC
  • Galderma S.A.
  • Gemini Pharmaceuticals, Inc.
  • Genomma Lab International
  • Glaxosmithkline Plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Kowa Company, Ltd.
  • Lake Consumer Products, Inc.
  • Manx Healthcare Limited
  • Mcm Klosterfrau Vertriebs Gmbh (Klosterfrau Healthcare Group)
  • Meda AB
  • Melaleuca, Inc.
  • Merck Corporate Headquarters
  • Merz Pharma
  • Mochida Pharmaceutical Co., Ltd.
  • Nepentes Sa/Nepentes Pharma Sp. Z O.O.
  • Neutrogena Corp.
  • Northeast Pharmaceutical Group Co. Ltd
  • Novartis International AG
  • Now Foods
  • Perrigo Plc
  • Pfizer Inc.
  • Pgt Healthcare (Division Of Procter & Gamble)
  • Pharmavite Llc
  • Pierre Fabre Pharmaceuticals Inc.
  • Piramal Healthcare Ltd
  • Prestige Brands Holdings, Inc.
  • Reckitt Benckiser Plc.
  • Recordati Pharma GMBH
  • Revolymer (U.K.) Ltd
  • Sage Products Llc
  • Sanofi
  • Sato Pharmaceutical Co., Ltd.
  • Shaklee Corporation
  • Stada Arzneimittel AG
  • Swisse Wellness Pty Ltd.
  • Taisho Pharmaceutical Holdings
  • Takeda Pharmaceuticals Ltd.
  • Tisso Naturprodukte GMBG
  • Wellspring Pharmaceutical Corporation
  • Zeavision, Llc

11: Appendix

  • Market Definitions
  • Common Administration Methods For OTC Drugs

12: Appendix

  • Smoking Cessation Initiatives

13: Appendix

  • OTC Markets 2013 Through 2018
  • Highlights Of The Year 2012
  • Trends In OTC Drugs And Dietary Supplements Through 2018
  • Forecast Trends In OTC Drugs By Therapeutic Class Through 2018

List Of Tables

Summary Table A : Global Therapeutic Markets For OTC Drugs, By Segment, Through 2021
Summary Table B : Regional Markets For Dietary Supplements, Through 2021
Table 1 : Global Markets For OTC Drugs And Dietary Supplements, Through 2021
Table 2 : Regional Markets For OTC Drugs And Dietary Supplements Through 2021
Table 3 : Global Market For OTC Drugs, By Therupeutic Classification, Through 2021
Table 4 : OTC Drugs Revenue By Location Of Sales, Through 2021
Table 5 : Dietary Supplements Revenue By Location Of Sales, Through 2021
Table 6 : North America OTC Drug Markets, Through 2021
Table 7 : North America Dietary Supplement Markets, Through 2021
Table 8 : North America Markets By Therapeutic Classification, Through 2021
Table 9 : Updated List Of Rx-To-OTC Switches In The U.S. From 2001 To 2016
Table 10 : The U.S. OTC Drug Markets, By Therapeutic Classifcations, Through 2021
Table 11 : Brazil OTC Drug Markets, By Therapeutic Classifications, Through 2021
Table 12 : European OTC Drug Markets, Through 2021
Table 13 : European OTC Drug Markets By Therapeutic Classifcations, Through 2021
Table 14 : U.K. Pom To P Reclassifications Up To October 2016
Table 15 : P To Gsl Reclassifications Up To October 2016
Table 16 : Recent Pom To P Reclassifications And Nonprescription Marketing Authorizations: U.K., 2010-2015
Table 17 : Recent P To Gsl Reclassifications And Nonprescription Marketing Authorizations - U.K., 2011-2015
Table 18 : The U.K. OTC Drug Market, By Therapeutic Classification, Through 2021
Table 19 : OTC Drug Switches In Germany From 2005 To 2016
Table 20 : Germany OTC Drug Markets By Therapeutic Classifcations, Through 2021
Table 21 : France OTC Drug Markets By Therapeutic Classifcations, Through 2021
Table 22 : Cce OTC Drug Markets, By Therapeutic Classifcations, Through 2021
Table 23 : Russian OTC Drug Markets, By Therapeutic Classifications, Through 2021
Table 24 : Polish OTC Drug Markets, By Therapeutic Classifications, Through 2021
Table 25 : Apac OTC Drug Markets, By Therapeutic Classifications, Through 2021
Table 26 : Reviews Conducted For OTC Drugs In Japan, By Fiscal Year, 2011-2015
Table 27 : Updated List Of OTC To First Kind Pharmaceutical Drugs In Japan, Nov. 2007-March 2016
Table 28 : Japan OTC Drug Markets, By Therapeutic Classifications, Through 2021
Table 29 : China OTC Drug Markets, By Therapeutic Classifications, Through 2021
Table 30 : India OTC Drug Markets, By Therapeutic Classifications, Through 2021
Table 31 : Australia And New Zealand OTC Drug Markets, By Therapeutic Classifications, Through 2021
Table 32 : Global Market Forecast For OTC Analgesics And Antipyretics, Through 2021
Table 33 : Global Market Forecast For OTC Antihistamine And Cough And Cold, Through 2021
Table 34 : Global Market Forecast For OTC Gastrointestinal Products, Through 2021
Table 35 : Global Market Forecast For OTC Dermatological Drugs, Through 2021
Table 36 : Global Market Forecast For OTC Oral Medical Care Products Through 2021
Table 37 : Global Market Forecast For OTC Eye Care Products, Through 2021
Table 38 : Global Market Forecast For OTC Smoking Cessation Products, By Region, Through 2021
Table 39 : Global Market Forecast For OTC Dietary Supplement Products, By Region, Through 2021
Table 40 : Swot Analysis Of The OTC Drug And Dietary Supplement Industry
Table 41 : Articles Reported To Have Highest Implementation Rates In 2012 Who Fctc Progress Report
Table 42 : Articles Reported Moderate Implementation Rates: 2012 Who Fctc Progress Report
Table 43 : Articles Reported Lowest Implementation Rates: 2012 Who Fctc Progress Report
Table 44 : Global Implemetation Of Fctc Articles: 2012 Report
Table 45 : Global Implementation Of Article 14 Of Fctc
Table 46 : Initiatives Implemented By Parties To Fctc Treaty In 2012
Table 47 : Projected Global Cause Of Death By Disease
Table 48 : Public Health Burden Due To Smoking-Related Diseases
Table 49 : Global Market For OTC Drugs And Dietary Supplements Through 2018

List Of Figures

Summary Figure A : Global Therapeutic Markets For OTC Drugs, By Segment, 2015-2021
Summary Figure B : Regional Markets For Dietary Supplements, 2015-2021
Figure 1 : Key Growth Factors For OTC Drugs
Figure 2 : Global Implementation Of Articles Of 2012 Who Fctc Progress Report
Figure 3 : Ongoing Studies, By Region
Figure 4 : Global Market For OTC Drugs And Dietary Supplements, 2011-2018

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Alacer Corp.
  • Bausch & Lomb
  • Daiichi Sankyo Co., Ltd.
  • Glaxosmithkline Plc
  • Neutrogena Corp.
  • Reckitt Benckiser Plc.
  • MORE

Analyst Credentials:

With more than 10 years of experience with market research publishers, management consultants and government bodies, Anand Gijare specializes in predictive and exploratory research projects for market demand potential, sizing and perceptions, as well as in analyzing macro and micro markets in terms of key gaps and opportunities. His expertise includes market trends and drivers, competitive scenarios, value chain analysis and in-depth global market forecasts. He has worked on research studies across a variety of industrial sectors, including pharmaceuticals, healthcare, and information and communication technology.

Note: Product cover images may vary from those shown
5 of 6
  • Alacer Corp.
  • Alcon Inc.
  • Alfresa Pharma Corporation
  • Alkalon A/S
  • Alliance Healthcare
  • Allergan, Plc.
  • Alticor
  • Arkopharma Pharmaceutical Laboratories (Laboratoires Pharmaceutiques)
  • Aspen Holdings
  • Bausch & Lomb
  • Bayer Healthcare AG
  • Boehringer Ingelheim GMBH
  • Carma Laboratories, Inc.
  • Chattem Inc.
  • Cilag AG
  • Colgate-Palmolive Company
  • Daiichi Sankyo Co., Ltd.
  • Derma Sciences
  • Eyescience Labs
  • Fertin Pharma A/S
  • Gaba Gmbh, PC
  • Galderma S.A.
  • Gemini Pharmaceuticals, Inc.
  • Genomma Lab International
  • Glaxosmithkline Plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Kowa Company, Ltd.
  • Lake Consumer Products, Inc.
  • Manx Healthcare Limited
  • Mcm Klosterfrau Vertriebs Gmbh (Klosterfrau Healthcare Group)
  • Meda AB
  • Melaleuca, Inc.
  • Merck Corporate Headquarters
  • Merz Pharma
  • Mochida Pharmaceutical Co., Ltd.
  • Nepentes Sa/Nepentes Pharma Sp. Z O.O.
  • Neutrogena Corp.
  • Northeast Pharmaceutical Group Co. Ltd
  • Novartis International AG
  • Now Foods
  • Perrigo Plc
  • Pfizer Inc.
  • Pgt Healthcare (Division Of Procter & Gamble)
  • Pharmavite Llc
  • Pierre Fabre Pharmaceuticals Inc.
  • Piramal Healthcare Ltd
  • Prestige Brands Holdings, Inc.
  • Reckitt Benckiser Plc.
  • Recordati Pharma GMBH
  • Revolymer (U.K.) Ltd
  • Sage Products Llc
  • Sanofi
  • Sato Pharmaceutical Co., Ltd.
  • Shaklee Corporation
  • Stada Arzneimittel AG
  • Swisse Wellness Pty Ltd.
  • Taisho Pharmaceutical Holdings
  • Takeda Pharmaceuticals Ltd.
  • Tisso Naturprodukte GMBG
  • Wellspring Pharmaceutical Corporation
  • Zeavision, Llc
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll